Evidence map›Paper›PMID 36789951›Full record

ArticleDevelopment (Cambridge, England)2023

Production and characterization of monoclonal antibodies to Xenopus proteins.

Brett Horr, Ryan Kurtz, Ankit Pandey, Benjamin G Hoffstrom, Elizabeth Schock, Carole LaBonne, Dominique Alfandari

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Spinal Cord Regeneration in Xenopus.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. A Dapl1Science advances · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Essential role of MgCell reports · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Brett HorrThe University of Massachusetts Amherst, Department of Veterinary and Animal Sciences, Amherst, MA 01003, USA.
Ryan KurtzThe University of Massachusetts Amherst, Department of Veterinary and Animal Sciences, Amherst, MA 01003, USA.
Ankit PandeyThe University of Massachusetts Amherst, Department of Veterinary and Animal Sciences, Amherst, MA 01003, USA.
Benjamin G HoffstromAntibody Technology Resource, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Elizabeth SchockDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA.
Carole LaBonneDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA.
Dominique AlfandariThe University of Massachusetts Amherst, Department of Veterinary and Animal Sciences, Amherst, MA 01003, USA.ORCID 0000-0002-0557-1246
University of Massachusetts Amherst · USNorthwestern University · USFred Hutch Cancer Center · US

Funding

Mechanism of Xenopus Cranial Neural Crest Cell MigrationR01DE016289 · NIDCR · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ALFANDARI, DOMINIQUE R · 2006 to 2022
$5.4M
Six1 Co-factors in Craniofacial DevelopmentR01DE026434 · NIDCR · GEORGE WASHINGTON UNIVERSITY · PI ALFANDARI, DOMINIQUE R, MOODY, SALLY ANN · 2018 to 2022
$1.9M
Production and characterization of monoclonal antibodies to Xenopus ProteinsR24OD021485 · OD · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ALFANDARI, DOMINIQUE R · 2017 to 2020
$1.2M
Neural Crest Ontogeny and the Control of Stem Cell AttributesR01GM116538 · NIGMS · NORTHWESTERN UNIVERSITY · PI LABONNE, CAROLE · 2015 to 2018
$1.2M
Acquisition of an Orbitrap MSS10OD010645 · OD · UNIVERSITY OF MASSACHUSETTS AMHERST · PI EYLES, STEPHEN J. · 2013 to 2013
$600k
NIDCR NIH HHS R01 DE016289NIDCR NIH HHS R01 DE026434NIGMS NIH HHS R01 GM116538NIH HHS R24 OD021485NIH HHS S10 OD010645
6 · The paper itself

Abstract

Monoclonal antibodies are powerful and versatile tools that enable the study of proteins in diverse contexts. They are often utilized to assist with identification of subcellular localization and characterization of the function of target proteins of interest. However, because there can be considerable sequence diversity between orthologous proteins in Xenopus and mammals, antibodies produced against mouse or human proteins often do not recognize Xenopus counterparts. To address this issue, we refined existing mouse monoclonal antibody production protocols to generate antibodies against Xenopus proteins of interest. Here, we describe several approaches for the generation of useful mouse anti-Xenopus antibodies to multiple Xenopus proteins and their validation in various experimental approaches. These novel antibodies are now available to the research community through the Developmental Study Hybridoma Bank (DSHB).

Indexed as

Antibodies, MonoclonalXenopus ProteinsAnimalsHybridomasMiceXenopus laevisAntibodies, MonoclonalXenopus ProteinsHybridomaMethodMonoclonal AntibodyXenopus

Identifiers

PMID36789951
PMCPMC10112901
OpenAlexW4320709632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.